Recent breakthroughs in ALS research are fundamentally changing the landscape, giving patients and researchers real, tangible hope through autoimmune discoveries and gene therapies.
Exploring the scientific paradox of riluzole's failure in a transgenic TDP-43 rat model despite its proven clinical efficacy in human ALS patients.
Discover how proteogenomics is revolutionizing ALS research by revealing how CCNF gene mutations trigger cell death pathways in motor neurons.
Discover the groundbreaking research revealing how ALS and FTD, once thought to be separate conditions, are actually two manifestations of the same underlying disease process.
Exploring the overlapping characteristics of amyotrophic lateral sclerosis and frontotemporal dementia, from genetics to clinical manifestations.
Discover how preventing SUMOylation at lysine 75 could inhibit mutant SOD1 aggregation in ALS, offering new therapeutic approaches for this neurodegenerative disease.
Discover how the OPTN-K489E mutation disrupts cellular balance and accelerates ALS progression through enhanced apoptosis, necroptosis, and autophagy pathways.